Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
Sentante is developing a teleoperated/remote surgical robot for the performance of fully-robotic endovascular interventions.
NERv Technology's plug-and-play technology integrates seamlessly with existing peritoneal drains and catheters to provide physicians with active patient monitoring of leakage-related surgical complications.
Cyber Surgery is developing a high precision surgical robot for spinal surgery.
Suture-Tight catheter sutures secure endovascular aortic grafts to the aorta at the time of implant or during repair procedures.
Affluent Medical's cardiovascular products consist of the Kalios annuloplasty device that can be adjusted percutaneously and the Epygon, a bio-prosthesis for transapical mitral valve replacement.
Virtonomy has developed an end-to-end digital twin and simulation solution to perform clinical development and testing in a virtual environment to accelerate development and reduce risks, expenses, and regulatory burdens.
Activ Surgical utilizes AI, near-infrared fluorescent imaging, and robotics to enhance surgical vizualition and navigation beyond what is visible from traditional imaging systems (e.g. endoscopy).
The PEONY device uses technology that promotes selective muscle tissue proliferation to reinforce the pelvic floor and treat pelvic floor weakness and incontinence.
CardiaCare's wearable device utilizes medical grade artificial intelligence predict and deliver personalized, non-invasive electrical stimulation to the median Vagus nerve to reduce the occurrence of premature atrial contractions that are a precursor to episodes of atrial fibrillation.
Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia.
Inner Cosmos' digital pill is a subcutaneously implanted brain-computer interface (BCI) to rebalance the brain.
Paragate Medical is developing an implantable peritoneal ultrafiltration device that functions as a mechanical bypass too the kidneys and maintain fluid balance in patients with kidney or chronic heart failure.
Pacertools' PaCRTool provides healthcare professionals with quantifiable evidence to determine when CRT is effectively applied to heart failure patients and ensure synergy from biventricular pacing.
Serac's Seracam is a high-resolution hybrid gamma camera for the molecular imaging of radio-labelled tracers within the body. Seracam is designed to be a truly portable solution that can be taken outside of the nuclear medicine department and to the patient, including in outpatient clinics, physician offices, ICUs, and ORs.
X-Bolt develops next-generation devices for use during trauma surgeries. Key to the company's portfolio of orthopedic products are its expanding bolt design and the ability to easily reverse and remove implanted devices.
Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur.
Aortyx is developing a biomimetic, bioresorbable endovascular patch that is deployed via an endovascular catheter. The patch is designed to cover an aortic tear, stop false lumen blood flow, and promote natural repair and bio-integration at the tear site.
Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. Their innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently.
The Empress system is intended to treat symptomatic uterine fibroids, in a laparoscopic procedure, by inducing fibroid tissue ischemia.
Gradient Denervation Technologies is using thermal ablation to reduce pulmonary pressure in patients with pulmonary hypertension. The technology will target the nerves responsible for the hyperactivity of the pulmonary artery nerves to produce a long-term reduction in pulmonary pressure.
This Panel was Moderated by Oscar Jofre, Co-Founder, President & CEO, KoreConX. He was joined by Panelists: Joseph McGinley, Founder & CEO, McGinley Orthopedics, Marc Giroux, CEO, Kurve Therapeutics, Peter Kassel, CEO, HealthySole, Douglas Ruark, President, Regulation D Resources, and Manny Villafana, CEO of Medical 21.
CEO, Manny Villafana and Medical 21 are developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.
McGinley Orthopedics have developed the IntelliSense Drill, an innovative handheld robotic technology which can change the standard of care in orthopedic procedures.
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits.
Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur. The company's platform evaluates an individual's risk by interrogating 800 digital biomarkers collected through a digital assessment and augmented reality (AR).
Altoida is using technology to predict the onset of neurological diseases, such as Alzheimer's disease, before symptoms occur. The company's platform evaluates an individual's risk by interrogating 800 digital biomarkers collected through a digital assessment and augmented reality (AR).
Neurovine's platform consists of a wearable headband that utilizes electroencephalogram (EEG) and machine learning to provide patients with real-time reports on brain health.
Proxima works with emerging medical device companies across all phases of development. As a contract research organization, they organize their team in these distinct areas: regulatory and quality consulting and all-inclusive clinical trial services.
President & CEO, Todd Usen of Activ Surgical are utilizing AI, near-infrared fluorescent imaging, and robotics to enhance surgical visualition and navigation beyond what is visible from traditional imaging systems (e.g. endoscopy).
Rapid Nexus Nanotech Wound Solutions is an innovative wound company whose technology is based on nanomaterials and targets the electromagnetic cell division cycles (anaphase through telophase) to accelerate growth of tissue.